当前位置:主页 > 医学论文 > 心血管论文 >

当归补血汤联合卡维地洛治疗心肌缺血疗效观察

发布时间:2018-03-02 09:09

  本文关键词: 当归补血汤 卡维地洛 心肌缺血 左室功能 出处:《中药药理与临床》2017年02期  论文类型:期刊论文


【摘要】:目的:探讨当归补血汤联合卡维地洛治疗心肌缺血的临床疗效及应用价值。方法:选取120例冠心病心肌缺血患者,随机分为2组,即对照组和观察组,每组60例。对照组患者给予卡维地洛治疗,观察组采用当归补血汤联合卡维地洛治疗。比较两组患者治疗前后的总有效率和相关生理指标的差异。结果:实验结果发现,两组患者在治疗后均有好转,但观察组的总有效率(85%)明显高于对照组(71.7%);观察组患者在心电图ST段压低次数、持续时间及心肌缺血总负荷下降比对照组明显;在左室舒张功能上,对照组治疗前后变化不明显,观察组下降明显。结论:采用当归补血汤联合卡维地洛治疗心肌缺血效果优于卡维地洛单用的治疗效果。
[Abstract]:Objective: to investigate the clinical efficacy and application value of Danggui Buxue decoction (Danggui Buxue decoction) combined with Carvedilol in the treatment of myocardial ischemia. Methods: 120 patients with myocardial ischemia of coronary heart disease were randomly divided into two groups: control group and observation group. 60 patients in each group were treated with carvedilol in the control group, and those in the observation group were treated with Danggui Buxue decoction combined with carvedilol. The difference of the total effective rate and related physiological indexes between the two groups before and after treatment was compared. The total effective rate of the observation group was significantly higher than that of the control group (71.7%), the number of St segment depression, the duration and the total load of myocardial ischemia in the observation group were significantly lower than those in the control group, and the left ventricular diastolic function was lower in the observation group than in the control group. Conclusion: the therapeutic effect of Danggui Buxue decoction combined with carvedilol on myocardial ischemia is better than that of carvedilol alone.
【作者单位】: 南阳市中心医院;
【分类号】:R542.2

【相似文献】

相关期刊论文 前3条

1 刘康永,张秉琴,张毅,马宜明,冯振兴;当归补血汤加味治疗冠心病的临床研究[J];安徽中医学院学报;1997年06期

2 高焕;袁捷;程小红;;当归补血汤联合促红细胞生成素治疗肾性贫血34例[J];河南中医;2014年03期

3 ;[J];;年期

相关会议论文 前1条

1 李祯祥;;中医辨证施施治并西药治疗骨髓增生异常综合症57例疗效观察[A];第六届全国中西医结合血液病学术会议论文汇编[C];2002年



本文编号:1555894

资料下载
论文发表

本文链接:https://www.wllwen.com/yixuelunwen/xxg/1555894.html


Copyright(c)文论论文网All Rights Reserved | 网站地图 |

版权申明:资料由用户33ef7***提供,本站仅收录摘要或目录,作者需要删除请E-mail邮箱bigeng88@qq.com